“4D Molecular Therapeutics, Inc. Submits 8-K Filing to SEC (0001650648) as Filer”

**Significance of the SEC Filing:**
4D Molecular Therapeutics, Inc. recently submitted an 8-K filing to the Securities and Exchange Commission, indicating a significant event that shareholders and investors should be aware of. This filing typically denotes important information that could impact the company’s financial position or strategic direction.

**Company Overview:**
4D Molecular Therapeutics, Inc. is a biopharmaceutical company focused on developing gene therapies for severe genetic disorders. Their innovative approach utilizes targeted and customizable vectors to deliver therapeutic genes to specific cells in the body. With a commitment to advancing precision medicine, the company aims to address unmet medical needs and improve patient outcomes. For more information about 4D Molecular Therapeutics, Inc., please visit their official website.

**SEC Form Type:**
The 8-K filing submitted by 4D Molecular Therapeutics, Inc. is a report of unscheduled material events or corporate changes that are of importance to shareholders and the SEC. This form provides transparency and ensures that investors are informed about developments that could impact the company’s operations or financial health.